Analyst Ratings for aTyr Pharma (LIFE) [Buys]
LIFE Rating Summary
LIFE Price Target Summary
- Highest: $20.00 (Piper Sandler)
- Lowest: $16.00 (RBC Capital)
- Average: $18.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$18.00 (+1025%)
* Over Last 12-Mos
Rating Score: 5.5 / 10
Percentile Rank: 59%
Avg. $ Target:
$18.00 (+1025%)
* Over Last 12-Mos
Rating Score: 5.5 / 10
Percentile Rank: 59%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/3/2023 | Roth/MKM | Kumaraguru Raja | New Coverage | Buy (N/A) |
9.00 (N/A) |
2.12 (1.60) |
-24.53% | Details |
| 10/12/2021 | RBC Capital » Updated 3/15/2024 |
Kennan MacKay | New Coverage | Outperform (N/A) |
16.00 (19.00) |
9.42 (1.60) |
-83.01% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
